3D Systems Securities Class Action Lawsuit
Analysis based on 22 articles · First reported Jun 16, 2025 · Last updated Aug 07, 2025
The class action lawsuit against 3D Systems Corporation could lead to significant financial liabilities for the company, potentially impacting its stock price and investor confidence. The allegations regarding understated customer spending impact and negative effects on Regenerative Medicine Program revenue due to changes in the United Therapeutics partnership suggest potential operational and financial weaknesses.
A class action lawsuit has been filed against 3D Systems Corporation by Rosen Law Firm and The Gross Law Firm on behalf of investors who purchased securities between August 13, 2024, and May 12, 2025. The lawsuit alleges that 3D Systems made false and misleading statements by understating the impact of weakened customer spending and overstating its resilience. Additionally, it claims that updated milestone criteria in its partnership with United Therapeutics Corporation would negatively affect 3D Systems' Regenerative Medicine Program revenue. Investors are encouraged to secure counsel before the August 12, 2025, lead plaintiff deadline.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard